IQVIA
Clinical Trial Services (CRO) · Health Data & Interoperability

IQVIA revenue, results and funding

IQVIA filed revenue of $16.3B for 2025.

Data updated Nov 22, 2026 · Back to the company report
$16.3BRevenue, 2025
$1.4BNet income, 2025
93,000Employees, 2025
IQVNew York Stock Exchange

Results by year

YearRevenueNet incomeTotal assetsEmployeesLANG_CR_S_M_TAX_PAIDLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_DIVIDENDSLANG_CR_S_M_BUYBACKSLANG_CR_S_M_CAPEXLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_OPERATING_INCOMELANG_CR_S_M_CASHLANG_CR_S_M_DEBTLANG_CR_S_M_ACQUISITIONS
2025$16.3B$1.4B$29.9B93,000–$252M–$1.2B$603M$247M–$2.2B$2B$13.9B$1.7B
2024$15.4B$1.4B$26.9B88,000$295M$301M–$1.4B$602M$206M–$2.2B$1.7B$12.8B$735M
2023$15B$1.4B$26.7B87,000$340M$101M–$992M$649M$217M–$2B$1.4B$13B$876M
2022$14.4B$1.1B$25.3B86,000$255M$260M–$1.2B$674M$194M–$1.8B$1.2B$12.6B$1.3B
2021$13.9B$966M$24.7B79,000$222M$163M–$406M$640M$170M–$1.4B$1.4B$12B$1.5B
2020$11.4B$279M$24.6B70,000$209M$72M–$447M$616M$95M–$731M$1.8B$12.4B$177M
2019$11.1B$191M$23.3B67,000$215M$116M–$949M$582M$146M–$777M$837M$11.5B$588M
2018$10.4B$259M$22.5B58,000$211M$59M–$1.4B$459M$113M–$741M$891M$10.9B$309M
2017$9.7B$1.3B$22.9B55,000$195M−$992M–$2.6B$369M$106M–$665M$959M$10.1B$854M
2016$6.9B$72M$21.2B50,000$106M$325M–$1.1B$164M$106M–$576M$1.2B$7.1B−$1.9B
2015$5.7B$387M$3.9B36,100$121M$159M–$515M$78M$38M$3.3M$646M$977M$2.4B−$32M
2014$5.5B$357M$3.3B32,600$139M$149M–$415M$83M$30M$5.8M$590M$867M$2.3B$92M
2013$5.1B$226.6M$3.1B28,200$71M$96M–$6.4M$88.3M$22.8M$5M$462.3M$777M$2B$145M
2012$4.9B$177.5M$2.5B–$104M$93.4M$567.9M$13.4M$71.3M$25.9M$10.4M$396.4M$567.7M$2.4B$43.2M
2011$4.3B$241.8M$2.3B–$63.4M$15.1M$288.3M$14.3M$75.7M$14.1M$10M$345.3M$516.3M–$227.1M
Sources: SEC

How to cite

IQVIA, Financials. Alion, Nov 22, 2026. https://alion.io/company/iqvia/financials

.json · .md · CC BY-SA 4.0